🔗 Share this article

An high-ranking health officer has been removed of participation in a key medical study concerning puberty blockers after allegations of partiality emerged.

Alleged Intervention Led to Study Pause

As reported by media reports, Prof Jacob George, a chief medical and scientific officer for the regulatory agency, raised worries which led to the halting of a national clinical study during February.

This agency announced this weekend that George would recuse himself of any role with the trial after gender-critical online remarks made last year were identified.

Nature Regarding the Online Comments

In one statement, George referred to author J.K. Rowling as an asset of this era.” Separately, the professor remarked how the refusal of basic biological fact was worrisome” in regards to questions over a elite athlete’s sex.

The regulator stated that although George’s posts occurred before his role began, the official had been taken off of oversight in the study as a preventative measure.

Details Regarding the Paused Pathways Study

The research project, that was designed to assess the effect from puberty blockers for adolescents uncertain about their own gender, was due to begin recruiting subjects in the start of the year.

But, it was suspended in February after the regulatory body raised apprehensions about the wellbeing of children and young people taking part.

• The most junior subjects were projected to start at ten to eleven for assigned female at birth and eleven to twelve for assigned male at birth.
• The research leadership stated at the time that the thorough screening process meant those enrolled would likely be older.
• But, the agency have since stated the lowest age limit should be fourteen owing to an “unquantified risk” of “long-term health consequences.”

The study had planned to include around 226 youths over the coming three years.

Context Following the Cass Review

This trial was commissioned subsequent to a suggestion from a major report on youth gender identity services, that determined how the standard of the studies suggesting to show the benefits of this type of drugs in adolescents with gender incongruence were low-quality.”

Dr Hilary Cass, who led that inquiry, had earlier said her findings exposed an extremely poor scientific foundation” supporting the efficacy of such treatments.

She continued, since there exist medical professionals, children as well as families that believe strongly of the beneficial effects, a trial remained the sole method forward to clarify this.”

Expert Concern of the Decision

Dr Max Davie, an expert in adolescent medicine, stated there was no strong evidence-based justification to halt the research.

“The social media posts by Professor George give a clear indication into his individual stance on this issue,” Dr. Davie remarked. “The professor is quite at liberty to have any opinions about this subject he chooses, but what he cannot do would be to let these opinions to impact the execution of his regulatory responsibilities.”

He concluded: “For clarity, there is no definitive scientific reason to pause the Pathways trial. While Prof George’s own views is not the only possible explanation of the regulator’s unexpected change of position, they are the single factor for which evidence.”

Agency Response Regarding Next Steps

A MHRA spokesperson stated: “With all medical studies, the MHRA’s primary concern is the safety and welfare for the volunteers. In line with this duty, complex studies are kept constantly being monitored while the MHRA maintains a continuous conversation with study funders.”

“The MHRA has world-class scientific, medical and oversight professionals that operate as a collaborative group to deliver scientifically sound decisions on clinical trials. This team will continue to meet alongside the university to navigate the subsequent actions in a positive manner.”

“Following the identification regarding social media comments made before his tenure began, Prof Jacob George has been recused from further involvement on the Pathways study as an preventative step.”